ID SKW-3 AC CVCL_2197 SY SKW3 DR BTO; BTO_0006057 DR CLO; CLO_0009068 DR CLO; CLO_0051007 DR CLDB; cl4362 DR BioSample; SAMN03151818 DR BioSample; SAMN03473523 DR cancercelllines; CVCL_2197 DR CLS; 300343 DR Cosmic; 913412 DR Cosmic; 919156 DR Cosmic; 933546 DR Cosmic; 1524820 DR Cosmic; 1641385 DR DSMZ; ACC-53 DR DSMZCellDive; ACC-53 DR FANTOM5_SSTAR; 10416-106C2 DR NCBI_Iran; C182 DR RCB; RCB1168 DR TKG; TKG 0247 DR Wikidata; Q108821313 RX DOI=10.1016/B978-0-12-221970-2.50457-5; RX PubMed=2985879; RX PubMed=3159941; RX PubMed=3874327; RX PubMed=7849311; RX PubMed=8127147; RX PubMed=8641406; RX PubMed=9510473; RX PubMed=9933131; RX PubMed=15472075; RX PubMed=20143388; WW Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx WW Info; T-ALL cell lines db; -; https://humantallcelllines.wordpress.com/comprehensivetable/skw-3-ke-37/ CC Problematic cell line: Contaminated. Shown to be a KE-37 derivative (PubMed=20143388). Originally thought to originate from the peripheral blood of a 61 year old male patient with T cell chronic lymphocytic leukemia. CC Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00346. CC Population: Caucasian. CC Doubling time: ~30-40 hours (DSMZ=ACC-53); ~30 hours (CLS=300343). CC Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Gln2459Ter (c.7375C>T); Zygosity=Heterozygous (PubMed=15472075). CC Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; p.Arg571Gln (c.1712G>A); ClinVar=VCV000819886; Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Gly310Glu (c.929G>A); ClinVar=VCV000237678; Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro153Alafs*28 (c.455dupC) (c.455_456insC) (p.P152fs) (c.459_460insC); ClinVar=VCV000182958; Zygosity=Heterozygous (from parent cell line). ST Source(s): CLS=300343; DSMZ=ACC-53; RCB=RCB1168; TKG=TKG 0247 ST Amelogenin: X,Y ST CSF1PO: 10,12 ST D12S391: 19,22 ST D13S317: 8,12 ST D16S539: 11,12 ST D18S51: 13,18 ST D19S433: 13,15 ST D1S1656: 15.3,16 ST D21S11: 28,29,30 (CLS=300343) ST D21S11: 28,30 (DSMZ=ACC-53) ST D2S1338: 19,25 ST D3S1358: 15,18 ST D5S818: 12,13 ST D6S1043: 18,21 ST D7S820: 8,12 ST D8S1179: 11,14 ST FGA: 24,25 ST Penta D: 11,15 ST Penta E: 5,14 ST TH01: 6,9.3 ST TPOX: 8 ST vWA: 17,18 DI NCIt; C9142; Adult T acute lymphoblastic leukemia DI ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia OX NCBI_TaxID=9606; ! Homo sapiens (Human) HI CVCL_1327 ! KE-37 SX Male AG 27Y CA Cancer cell line DT Created: 04-04-12; Last updated: 10-04-25; Version: 33 CH CVCL_J125 ! SK-beta2.7 CH CVCL_4V58 ! SKW3/Clo // RX PubMed=3159941; DOI=10.1016/0145-2126(85)90134-1; RA Drexler, Hans Gunther RA Gaedicke, Gerhard RA Minowada, Jun RT "Isoenzyme studies in human leukemia-lymphoma cell lines -- III. RT Beta-hexosaminidase (E.C. 3.2.1.30)."; RL Leuk. Res. 9:549-559(1985). // RX PubMed=8641406; DOI=10.1111/j.1600-0609.1996.tb00721.x; RA Borgonovo-Brandter, Laura RA Heyman, Mats RA Rasool, Omid RA Liu, Yie RA Grander, Dan RA Einhorn, Stefan RT "p16INK4/p15INK4B gene inactivation is a frequent event in malignant RT T-cell lines."; RL Eur. J. Haematol. 56:313-318(1996). // RX PubMed=7849311; DOI=10.1182/blood.V85.4.893.bloodjournal854893; RA Stranks, Gail RA Height, Susan E. RA Mitchell, Paul RA Jadayel, Dalal Mouneimne RA Yuille, Martin A.R. RA De Lord, Corinne F.M. RA Clutterbuck, Robyn D. RA Treleaven, Jennie G. RA Powles, Ray Leonard RA Nacheva, Elisabeth RA Oscier, David G. RA Karpas, Abraham RA Lenoir, Gilbert Marcel RA Smith, Stephen D. RA Millar, John L. RA Catovsky, Daniel RA Dyer, Martin John Swinnerton RT "Deletions and rearrangement of CDKN2 in lymphoid malignancy."; RL Blood 85:893-901(1995). // RX PubMed=9933131; DOI=10.1016/S0145-2126(98)00133-7; RA Burger, Renate RA Hansen-Hagge, Thomas E. RA Drexler, Hans Gunther RA Gramatzki, Martin RT "Heterogeneity of T-acute lymphoblastic leukemia (T-ALL) cell lines: RT suggestion for classification by immunophenotype and T-cell receptor RT studies."; RL Leuk. Res. 23:19-27(1999). // RX DOI=10.1016/B978-0-12-221970-2.50457-5; RA Drexler, Hans Gunther RT "The leukemia-lymphoma cell line factsbook."; RL (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001). // RX PubMed=15472075; DOI=10.1126/science.1102160; RA Weng, Andrew P. RA Ferrando, Adolfo A. RA Lee, Woojoong RA Morris, John P. 4th RA Silverman, Lewis B. RA Sanchez-Irizarry, Cheryll RA Blacklow, Stephen Charles RA Look, Alfred Thomas RA Aster, Jon Christopher RT "Activating mutations of NOTCH1 in human T cell acute lymphoblastic RT leukemia."; RL Science 306:269-271(2004). // RX PubMed=9510473; DOI=10.1111/j.1349-7006.1998.tb00476.x; PMCID=PMC5921588; RA Hosoya, Noriko RA Hangaishi, Akira RA Ogawa, Seishi RA Miyagawa, Kiyoshi RA Mitani, Kinuko RA Yazaki, Yoshio RA Hirai, Hisamaru RT "Frameshift mutations of the hMSH6 gene in human leukemia cell RT lines."; RL Jpn. J. Cancer Res. 89:33-39(1998). // RX PubMed=20143388; DOI=10.1002/ijc.25242; RA Capes-Davis, Amanda RA Theodosopoulos, George RA Atkin, Isobel RA Drexler, Hans Gunther RA Kohara, Arihiro RA MacLeod, Roderick A.F. RA Masters, John R.W. RA Nakamura, Yukio RA Reid, Yvonne A. RA Reddel, Roger Robert RA Freshney, Robert Ian RT "Check your cultures! A list of cross-contaminated or misidentified RT cell lines."; RL Int. J. Cancer 127:1-8(2010). // RX PubMed=2985879; DOI=10.1016/0145-2126(85)90084-0; RA Drexler, Hans Gunther RA Gaedicke, Gerhard RA Minowada, Jun RT "Isoenzyme studies in human leukemia-lymphoma cell lines -- 1. RT Carboxylic esterase."; RL Leuk. Res. 9:209-229(1985). // RX PubMed=3874327; DOI=10.1016/0145-2126(85)90133-x; RA Drexler, Hans Gunther RA Gaedicke, Gerhard RA Minowada, Jun RT "Isoenzyme studies in human leukemia-lymphoma cells lines -- II. Acid RT phosphatase."; RL Leuk. Res. 9:537-548(1985). // RX PubMed=8127147; RA Heyman, Mats RA Grander, Dan RA Brondum-Nielsen, Karen RA Cederblad, Britta RA Liu, Yie RA Xu, Bo RA Einhorn, Stefan RT "Interferon system defects in malignant T-cells."; RL Leukemia 8:425-434(1994). //